Contact Us
Drug Search Results
More Filters [+]

Lisuride

Alternative Names: lisuride, dopergin
Latest Update: 2024-04-16
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: D2 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Subcutaneous,Transdermal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Chile | Colombia | Dominican Republic | Egypt | France | Germany | Ireland | Italy | Mexico | New Zealand | Pakistan | Peru | Portugal | Taiwan | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Axxonis Pharma AG
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lisuride

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Psychomotor Agitation|Restless Legs Syndrome|Parkinson's Disease

Phase 2: Hypertension, Pulmonary|Parkinson's Disease

Phase 1: Cocaine-Related Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Lis-Safe

P2

Terminated

Hypertension, Pulmonary

2014-08-19

TULEP 1

P3

Active, not recruiting

Parkinson's Disease

2008-09-20

Tulir03/01

P3

Active, not recruiting

Restless Legs Syndrome

2007-09-08

2004-001589-42

P3

Active, not recruiting

Restless Legs Syndrome

2006-08-25

Recent News Events

Date

Type

Title

04/16/2024

PubMed

 Testing of putative antiseizure medications in a preclinical Dravet syndrome zebrafish model.

03/01/2024

PubMed

 Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?

02/05/2024

PubMed

 Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions